Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option?
Authors:
- 13 May 2020
- journal article
- research article
- Published by Springer Nature in La radiologia medica
- Vol. 126 (1) , 155-162
Abstract
Aim Stereotactic ablative radiation therapy (SABR) is used in non-oncologic indications, recently even for cardiac arrhythmias. Thus, aim of this analysis is to review preclinical, early clinical evidences and future direction of the latter new treatment approach. Method A collection of available data regarding SABR and cardiac arrhythmias was made, by Pubmed research and 2 independent researchers, including preclinical and clinical data. A review of ongoing trials was conducted on ClinicalTrials.gov. Results Preclinical research conducted in animal models showed that a safe and effective noninvasive treatment approach for cardiac arrhythmias could be represented by SABR with a median time of response around 2–3 months. The treatment dose plays a crucial role: the atrioventricular node would seem more radiosensitive than the other cardiac electric zones. Clinical data, such as published case series, case reports and early prospective studies, have already suggested the feasibility, efficacy and safety of SABR (25 Gy in one session) for refractory ventricular arrhythmias. Conclusion Considering the ongoing trials of SABR and new technological improvements in radiotherapy (e.g. hybrid magnetic resonance) and in arrhythmias noninvasive mapping systems, the future analyses will improve the reliability of those preliminary results.Keywords
This publication has 30 references indexed in Scilit:
- Mastering the art of epicardial access in cardiac electrophysiologyHeart Rhythm, 2019
- Noninvasive cardiac arrhythmia ablation with particle beamsMedical Physics, 2018
- Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancerStrahlentherapie und Onkologie, 2018
- Stereotactic body radiation therapy for liver oligometastases: predictive factors of local response by 18F-FDG-PET/CTBritish Journal of Radiology, 2018
- Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided deliveryStrahlentherapie und Onkologie, 2018
- Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapyInternational Journal of Cardiology, 2018
- Catheter AblationCardiac Electrophysiology Clinics, 2017
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- The Role of Stereotactic Ablative Radiotherapy in Oncological and Non-Oncological Clinical Settings: Highlights from the 7th Meeting of AIRO – Young Members Working Group (AIRO Giovani)Tumori Journal, 2014
- Radiobiology of Stereotactic Body Radiation Therapy/Stereotactic Radiosurgery and the Linear-Quadratic ModelInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013